Higher frequency of TMEM199-CDG in the southern mediterranean area is associated with c.92G>C (p.Arg31Pro) mutation.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 07 05 2022
revised: 17 09 2022
accepted: 22 01 2023
pubmed: 28 1 2023
medline: 14 2 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

Congenital disorders of glycosylation (CDG) are genetic multisystem diseases, characterized by defective glycoconjugate synthesis. A small number of CDG with isolated liver damage have been described, such as TMEM199-CDG, a non-encephalopathic liver disorder with Wilson disease-like phenotype. Only eight patients with TMEM199-CDG have been described including seven Europeans (originating from Greece and Italy) and one Chinese. Three patients from southern Italy (Campania) shared the same known missense mutation pathogenetic variant NM_152464.3:c. 92G > C (p.Arg31Pro), also found in a Greek patient. Here we report a new patient from southern Italy (Sicily), with a homozygous c.92G > C p.(Arg31Pro) variant in TMEM199. The patient's phenotype is characterized by mild non-progressive hepatopathy with a normal hepatic echo structure. A persistent increase in serum transaminases, total and low-density lipoprotein cholesterol and low serum ceruloplasmin and copper levels and normal urinary copper excretion were observed. Matrix-assisted laser desorption/ionization mass spectrometry analyses showed abnormal N- and O- protein glycosylation, indicative of a Golgi processing defect and supporting the function of TMEM199 in maintaining Golgi homeostasis. TMEM199-CDG is an ultra-rare CDG relatively frequent in the southern Mediterranean area (7 in 9 patients, 77%). It is mainly associated with the c.92G > C (p.Arg31Pro) pathogenetic allele globally reported in 4 out of 7 families (57%), including one from Greece and three unrelated families from southern Italy. The almost uniform clinical phenotype described in patients with TMEM199-CDG appears to reflect a higher prevalence of the same variant in patients from the southern Mediterranean area.

Identifiants

pubmed: 36706865
pii: S1769-7212(23)00015-0
doi: 10.1016/j.ejmg.2023.104709
pii:
doi:

Substances chimiques

Copper 789U1901C5
TMEM199 protein, human 0
Membrane Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104709

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No conflicting interests are declared.

Auteurs

Agata Fiumara (A)

CRR-MET, Department of Clinical and Experimental Medicine, University of Catania, Italy.

Annamaria Sapuppo (A)

CRR-MET, Department of Clinical and Experimental Medicine, University of Catania, Italy.

Lorenzo Ferri (L)

Molecular Biology of Neurometabolic Diseases, Neuroscience Department, Meyer Children's Hospital, Florence, Italy.

Alessia Arena (A)

CRR-MET, Department of Clinical and Experimental Medicine, University of Catania, Italy.

Adriana Prato (A)

Child Neuropsychiatry- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Domenico Garozzo (D)

Institute of Polymers, Composites and Biomaterials - CNR, Catania, Italy.

Luisa Sturiale (L)

Institute of Polymers, Composites and Biomaterials - CNR, Catania, Italy.

Amelia Morrone (A)

Molecular Biology of Neurometabolic Diseases, Neuroscience Department, Meyer Children's Hospital, Florence, Italy; Department of NEUROFARBA, University of Florence, Florence, Italy.

Rita Barone (R)

CRR-MET, Department of Clinical and Experimental Medicine, University of Catania, Italy; Child Neuropsychiatry- Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Institute of Polymers, Composites and Biomaterials - CNR, Catania, Italy. Electronic address: rbarone@unict.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH